| Annual Financials | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | TTM |
Revenue  | 523 | 571 | 558 | 583 | 745 | 845 | 826 | 820 | 1,029 | 1,330 | 1,757 | 2,304 | 2,460 |
| Expenses | 529 | 547 | 507 | 525 | 657 | 711 | 678 | 719 | 838 | 1,111 | 1,462 | 2,014 | 2,209 |
| EBITDA | -6 | 23 | 51 | 59 | 88 | 134 | 148 | 101 | 191 | 219 | 295 | 291 | 251 |
| Operating Profit % | -2 % | 3 % | 7 % | 8 % | 10 % | 15 % | 17 % | 11 % | 16 % | 14 % | 15 % | 12 % | 9 % |
| Depreciation | 15 | 17 | 16 | 15 | 15 | 19 | 20 | 17 | 16 | 15 | 40 | 29 | 17 |
| Interest | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 2 | 5 | 6 |
| Profit Before Tax | -21 | 6 | 36 | 44 | 73 | 114 | 127 | 83 | 134 | 220 | 156 | 252 | 228 |
| Tax | 0 | 1 | 15 | 18 | 18 | 42 | 34 | 21 | 35 | 58 | 41 | 65 | 48 |
| Net Profit | -21 | 5 | 20 | 26 | 54 | 72 | 93 | 62 | 99 | 162 | 116 | 188 | 170 |
| EPS in ₹ | -8.34 | 2.10 | 8.00 | 10.40 | 21.80 | 28.90 | 37.30 | 24.60 | 39.70 | 64.60 | 46.30 | 75.01 | 67.80 |
AstraZeneca Pharma
AstraZeneca Pharma
7,251.50
+19.50
(0.27%)
Market Cap
18,128.75 Cr
PE Ratio
106.41
Volume
2,674.00
Day High - Low
7,275.00 - 7,208.50
52W High-Low
9,849.50 - 7,200.00
There are new updates from the company15 hrs ago
View
Key Fundamentals
Market Cap
18,128.75 Cr
EPS
75.01
PE Ratio
106.41
PB Ratio
20.68
Book Value
349.12
EBITDA
290.50
Dividend Yield
0.50 %
Industry
Healthcare Sector
Pharmaceuticals Return on Equity
21.49
Debt to Equity
0.09
Actual
Company News
View All News
AstraZeneca Pharma India Ltd disclosed an ESG rating of 57 from Crisil ESG Ratings on August 24, 2026. The assessment was based on public data without direct engagement.
AstraZeneca Pharma India Limited has scheduled a virtual one-on-one interaction with an institutional investor on August 26, 2026. The meeting is disclosed pursuant to SEBI Regulation 30.
AstraZeneca Pharma India Limited has scheduled a virtual one-on-one meeting with institutional investors for August 19, 2026, pursuant to SEBI Regulation 30.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,915.60 | #1 4,59,616.61 | 37.82 | #1 61,673.90 | 12.69 | #1 11,565 | 26.53 | 45.69 | |
8,599.00 | 2,28,276.43 | 77.15 | 11,067.00 | 13.95 | 2,568 | 65.50 | 67.19 | |
4,880.00 | 1,85,619.51 | 85.76 | 13,886.20 | 20.34 | 2,138 | 3.28 | 48.05 | |
1,421.50 | 1,14,835.21 | 34.55 | 29,044.60 | 2.24 | 3,870 | -39.18 | 48.21 | |
1,095.40 | 1,10,222.87 | 23.91 | 27,657.90 | 17.64 | 5,026 | -34.90 | 44.37 | |
1,844.00 | 99,549.55 | 89.01 | 6,867.80 | 22.01 | 890 | #1 123.93 | 59.80 | |
2,174.00 | 99,402.35 | #1 18.04 | 29,038.90 | #1 26.75 | 5,356 | 16.00 | 27.99 | |
1,186.40 | 99,025.14 | 31.32 | 35,058.60 | 3.90 | 4,158 | -69.10 | 48.40 | |
2,345.70 | 96,876.47 | 47.44 | 14,636.40 | 14.85 | 1,938 | 29.13 | 38.57 | |
1,609.00 | 92,578.30 | 24.96 | 34,145.20 | 5.56 | 3,503 | 25.21 | 51.29 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
31.15 %
Net Income Growth
62.06 %
Cash Flow Change
-123.16 %
ROE
43.08 %
ROCE
31.61 %
EBITDA Margin (Avg.)
-24.81 %
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
| Total Assets | 412 | 403 | 416 | 461 | 562 | 706 | 775 | 857 | 985 | 1,078 | 1,518 | 1,989 |
| Fixed Assets | 101 | 97 | 87 | 76 | 75 | 72 | 81 | 75 | 69 | 67 | 64 | 118 |
| Current Assets | 263 | 267 | 252 | 321 | 405 | 542 | 619 | 706 | 836 | 933 | 1,342 | 1,740 |
| Capital Work in Progress | 12 | 6 | 5 | 4 | 7 | 24 | 4 | 2 | 1 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 298 | 299 | 324 | 382 | 480 | 611 | 690 | 780 | 915 | 1,011 | 1,454 | 1,872 |
| Total Equity & Liabilities | 412 | 403 | 416 | 461 | 562 | 706 | 775 | 857 | 985 | 1,078 | 1,518 | 1,989 |
| Current Liabilities | 260 | 234 | 190 | 207 | 259 | 327 | 304 | 333 | 384 | 357 | 703 | 982 |
| Non Current Liabilities | 1 | 13 | 2 | 7 | 2 | 15 | 15 | 13 | 12 | 9 | 45 | 135 |
| Total Equity | 151 | 156 | 223 | 247 | 301 | 364 | 456 | 511 | 589 | 712 | 770 | 873 |
| Reserve & Surplus | 146 | 151 | 218 | 242 | 296 | 359 | 451 | 506 | 584 | 707 | 765 | 868 |
| Share Capital | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
| Net Cash Flow | -64 | 53 | 38 | -1 | 59 | -90 | 269 | 96 | 52 | 5 | 31 | -88 |
| Investing Activities | -19 | -4 | 0 | -9 | 4 | -171 | 173 | 5 | 18 | 22 | 31 | 19 |
| Operating Activities | -46 | 57 | 38 | 9 | 55 | 87 | 105 | 101 | 58 | 28 | 65 | -15 |
| Financing Activities | 0 | -1 | 0 | 0 | 0 | -6 | -9 | -10 | -25 | -44 | -66 | -92 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| Promoter | 75.00 % | 75.00 % | 75.00 % | 75.00 % | 75.00 % | 75.00 % | 75.00 % | 75.00 % | 75.00 % | 75.00 % | 75.00 % | 75.00 % | 75.00 % | 75.00 % | 75.00 % | 75.00 % | 75.00 % | 75.00 % | 75.00 % | 75.00 % | 75.00 % | 75.00 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 2.69 % | 0.00 % | 2.74 % | 2.79 % | 2.90 % | 2.93 % | 2.89 % | 3.03 % | 2.74 % | 2.71 % | 2.78 % | 2.68 % |
| DIIs | 0.83 % | 0.94 % | 0.96 % | 1.00 % | 1.02 % | 1.10 % | 1.12 % | 1.44 % | 1.42 % | 1.93 % | 2.43 % | 2.75 % | 3.78 % | 5.01 % | 5.10 % | 5.22 % | 4.65 % | 4.56 % | 5.26 % | 5.56 % | 5.80 % | 6.08 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 19.53 % | 19.72 % | 19.69 % | 19.44 % | 19.06 % | 18.62 % | 18.54 % | 18.56 % | 18.46 % | 18.12 % | 17.44 % | 17.09 % | 16.33 % | 15.00 % | 14.77 % | 14.62 % | 15.16 % | 15.18 % | 14.39 % | 14.14 % | 13.88 % | 13.76 % |
| Others | 4.64 % | 4.34 % | 4.34 % | 4.57 % | 4.92 % | 5.28 % | 5.34 % | 5.01 % | 5.12 % | 4.95 % | 2.44 % | 5.15 % | 2.15 % | 2.20 % | 2.23 % | 2.24 % | 2.31 % | 2.23 % | 2.61 % | 2.59 % | 2.55 % | 2.48 % |
| No of Share Holders | 0 | 63,753 | 68,077 | 66,444 | 62,183 | 57,760 | 53,980 | 49,085 | 42,146 | 38,946 | 32,380 | 29,032 | 29,418 | 27,169 | 27,615 | 27,322 | 32,466 | 34,378 | 32,914 | 31,551 | 29,007 | 29,338 |
Dividend History
| Annual Cash Flows | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 0.00 | 1 | 2 | 10 | 16 | 24 | 32 | 36 |
| Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 0.03 | 0.08 | 0.31 | 0.3 | 0.28 | 0.41 | 0.5 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 20 Aug 2021 |  Dividend | ₹ 2.00 /share | 18 Aug 2021 | 3,406.35 | 3,101.65 |
| 08 Jul 2022 | Dividend | ₹ 8.00 /share | 07 Jul 2022 | 2,635.15 | 2,898.90 |
| 08 Aug 2022 |  Annual General Meeting | NA | 08 Aug 2022 | 2,982.60 | 3,079.00 |
| 14 Jul 2023 | Dividend | ₹ 16.00 /share | 14 Jul 2023 | 3,253.00 | 3,767.35 |
| 05 Jul 2024 | Dividend | ₹ 24.00 /share | 05 Jul 2024 | 6,011.75 | 7,120.15 |
| 08 Aug 2024 | Annual General Meeting | NA | 08 Aug 2024 | 6,610.75 | 7,090.80 |
| 13 Nov 2024 |  Quarterly Result Announcement | NA | 13 Nov 2024 | 7,155.25 | 7,410.50 |
| 11 Feb 2025 | Quarterly Result Announcement | NA | 11 Feb 2025 | 6,920.30 | 7,535.10 |
| 30 May 2025 | Quarterly Result Announcement | NA | 30 May 2025 | 7,920.85 | 7,918.50 |
| 18 Jul 2025 | Dividend | ₹ 32.00 /share | 18 Jul 2025 | 7,918.50 | 9,386.25 |
| 14 Aug 2025 | Annual General Meeting | NA | 14 Aug 2025 | 8,832.65 | 8,416.50 |
| 14 Aug 2025 | Quarterly Result Announcement | NA | 14 Aug 2025 | 8,953.35 | 8,416.50 |
| 07 Nov 2025 | Quarterly Result Announcement | NA | 07 Nov 2025 | 9,302.50 | 9,182.50 |
| 11 Feb 2026 | Quarterly Result Announcement | NA | 11 Feb 2026 | 8,550.00 | 8,960.50 |
| 26 May 2026 | Quarterly Result Announcement | NA | 26 May 2026 | 8,695.50 | 8,800.00 |
| 31 Jul 2026 | Dividend | ₹ 36.00 /share | 31 Jul 2026 | 8,800.00 | 8,094.50 |
| 10 Aug 2026 | Annual General Meeting | NA | 10 Aug 2026 | 8,025.95 | 8,191.00 |
| 10 Aug 2026 | Quarterly Result Announcement | NA | 10 Aug 2026 | 8,300.00 | 8,191.00 |
Announcements
Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Disclosure Of ESG Rating
15 hrs ago
15 hrs agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation3 days ago
3 days agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation9 days ago
9 days agoShareholder Meeting / Postal Ballot-Scrutinizers ReportAug 12, 2026
Aug 12, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 11, 2026
Aug 11, 2026Shareholder Meeting / Postal Ballot-Outcome of AGMAug 10, 2026
Aug 10, 2026Outcome Of The Board Meeting Held On Monday August 10 2026Aug 10, 2026
Aug 10, 2026Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation 2015Aug 08, 2026
Aug 08, 2026Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company To Be Held On Monday August 10 2026Aug 04, 2026
Aug 04, 2026Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jul 30, 2026
Jul 30, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 29, 2026
Jul 29, 2026Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jul 28, 2026
Jul 28, 2026Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation 2015Jul 28, 2026
Jul 28, 2026Communication To The Shareholders W.R.T. TDS On DividendJul 22, 2026
Jul 22, 2026Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)Jul 21, 2026
Jul 21, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 20, 2026
Jul 20, 2026Record Date For Payment Of Final DividendJul 18, 2026
Jul 18, 2026Business Responsibility and Sustainability Reporting (BRSR)Jul 18, 2026
Jul 18, 2026Business Responsibility and Sustainability Reporting (BRSR)Jul 18, 2026
Jul 18, 2026Reg. 34 (1) Annual Report.Jul 18, 2026
Jul 18, 2026Notice Of The 47Th Annual General MeetingJul 18, 2026
Jul 18, 2026Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation 2015Jul 16, 2026
Jul 16, 2026Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Appointment Of Senior Management Personnel (SMP)Jul 06, 2026
Jul 06, 2026Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Appointment Of Senior Management PersonnelJun 16, 2026
Jun 16, 2026Closure of Trading WindowJun 15, 2026
Jun 15, 2026Information Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Resignation Of Senior Management PersonnelsJun 12, 2026
Jun 12, 2026Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation 2015Jun 11, 2026
Jun 11, 2026Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jun 04, 2026
Jun 04, 2026Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation 2015Jun 03, 2026
Jun 03, 2026Information Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Resignation Of Senior Management PersonnelJun 01, 2026
Jun 01, 2026Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 29, 2026
May 29, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 26, 2026
May 26, 2026Outcome Of The Board Meeting Held On Tuesday May 26 2026May 26, 2026
May 26, 2026Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation 2015May 21, 2026
May 21, 2026Determination Of Materiality - Details Of Key Managerial PersonnelMay 20, 2026
May 20, 2026Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company To Be Held On Tuesday May 26 2026May 20, 2026
May 20, 2026Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of AssociationMay 12, 2026
May 12, 2026Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of AssociationMay 12, 2026
May 12, 2026 Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportMay 12, 2026
May 12, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 29, 2026
Apr 29, 2026Shareholder Meeting / Postal Ballot-Notice of Postal BallotApr 10, 2026
Apr 10, 2026Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation 2015Apr 10, 2026
Apr 10, 2026Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Appointment Of Senior Management PersonnelMar 31, 2026
Mar 31, 2026 Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportMar 31, 2026
Mar 31, 2026Announcement under Regulation 30 (LODR)-Resignation of DirectorMar 20, 2026
Mar 20, 2026Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation 2015Mar 17, 2026
Mar 17, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Mar 13, 2026
Mar 13, 2026Closure of Trading WindowMar 13, 2026
Mar 13, 2026Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Appointment Of Senior Management PersonnelMar 11, 2026
Mar 11, 2026Shareholder Meeting / Postal Ballot-Notice of Postal BallotFeb 27, 2026
Feb 27, 2026Mutual Fund Holdings
Technical Indicators
RSI(14)
Neutral 23.55
ATR(14)
Volatile 202.37
STOCH(9,6)
Oversold 4.91
STOCH RSI(14)
Oversold 0.51
MACD(12,26)
Bearish -66.65
ADX(14)
Strong Trend 26.81
UO(9)
Bullish 24.20
ROC(12)
Downtrend And Accelerating -10.45
WillR(14)
Oversold -97.06
About AstraZeneca Pharma
AstraZeneca Pharma India Limited is a biopharmaceutical company incorporated in 1979. It manufactures, distributes, and markets pharmaceutical products, focusing on cardiovascular, renal and metabolism, oncology, and respiratory diseases. The company operates in the healthcare segment and provides clinical trial services to an overseas group company. Key products include Forxiga for...more
Website
Chairperson NameShilpa Divekar Nirula
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
